Compare Sumber Sinergi Makmur Tbk. (IOTF) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sumber Sinergi Makmur Tbk. vs Merck Tbk. — how do they compare? Sumber Sinergi Makmur Tbk. trades at Rp62 (market cap 338.58B, 17.89M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 5.2× Sumber Sinergi Makmur Tbk.'s market cap, and Sumber Sinergi Makmur Tbk. is more actively traded (17.89M versus 63K). Which is the better fit depends on your goals.
| IOTF | MERK | |
|---|---|---|
Market Cap | 338.58B | 1.76T |
Volume | 17.89M | 63K |
Lot | 178.94K | 630 |
Turnover | 1.13B | 243.97M |
Average Price | 62.89 | 3,872.46 |
Value | 1.13B | 243.97M |
Indicative Equilibrium Price | 62 | 3,900 |
Indicative Equilibrium Volume | 15.21K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sumber Sinergi Makmur Tbk.
PT Sumber Sinergi Makmur Tbk (the Company) was established based on Deed Number 88 dated May 19, 2015 of H. Zainuddin, S.H., a notary domiciled in Jakarta. The company started its commercial activities in 2015. The controlling party of the Company and the party who is the ultimate beneficial owner of the Company is Alamsyah.
Read more on IOTF →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
